Formed in 2013, OneOme works with physicians who place orders for patient test kits that the physician administers or are sent to directly the patient and back to the lab for DNA and bioinformatics analysis. This generates a personalized pharmacogenomic report in under 2 weeks at a cost of $249. Soon, this process will be integrated directly into the EMR experience.
OneOme is part of the Inveshure portfolio and co-developed in collaboration with algorithm IP from the Mayo Clinic. It is estimated that OneOme has now received $8m+ in capitalization to date.